Search

everythinglearnresearchcommunity

for

Search:↓

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

More men are choosing non-surgical aesthetic treatments, valuing expertise and ethical care.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Tamoxifen caused hair loss in a 52-year-old woman.

ABCG2 protein marks stem-like skin cells in human epidermis.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Breast cancer may be detectable through changes in scalp hair lipids.

Breast cancer patients need strong psychological support to improve their quality of life.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.